Poor
Not Aligned
Patient Risk:
Low
Summary
Multiple extracted claims (indications, routes of administration, safety/dosing/monitoring specifics, drug interactions, adverse reaction/counseling details) are not supported by the provided prescribing-information excerpts. The only safety concept partially reflected in the excerpts (hyperkalemia with potassium administration) appears to reference potassium citrate rather than potassium chloride, so the safety-related alignment is not reliable for KCl based on the provided text.
Category Scores
Accurate Statements
Too-high potassium levels (hyperkalemia) can cause serious problems.
5.1 Hyperkalemia (ID22) — states potentially fatal hyperkalemia and cardiac arrest (but the excerpt discusses potassium citrate, not potassium chloride).
Unsupported Statements
Potassium chloride (KCl) is used to treat low potassium (hypokalemia).
Absent from the provided label excerpts (no hypokalemia indication text included).
Potassium chloride (KCl) is used to prevent low potassium (hypokalemia).
Absent from the provided label excerpts.
Potassium chloride (KCl) may be used in some settings to provide potassium as part of repletion therapy.
Absent from the provided label excerpts.
Potassium chloride (KCl) can be taken orally.
No oral route information is present in the provided excerpts.
Potassium chloride (KCl) can be given by injection.
No injection route information is present in the provided excerpts.
The dosing route matters for potassium chloride because potassium can be dangerous if administered too quickly or in excessive amounts.
No route/timing/excess dosing safety guidance is present in the provided excerpts.
Hyperkalemia can cause heart rhythm disturbances.
The provided excerpt mentions cardiac arrest but does not mention heart rhythm disturbances.
Safety of potassium chloride depends on correct dosing.
No potassium chloride dosing-related safety statement is present in the provided excerpts.
Safety of potassium chloride depends on appropriate route.
No route-related safety statement is present in the provided excerpts.
Safety of potassium chloride depends on monitoring.
Monitoring is described in the excerpt, but it is specifically in the context of potassium citrate; no KCl-specific monitoring dependence is provided in the excerpts.
Monitoring is especially important in patients with kidney disease when taking potassium chloride.
The excerpt refers to potassium citrate and chronic renal failure; it does not specifically state this for potassium chloride.
Monitoring is especially important in patients taking other medications that affect potassium when taking potassium chloride.
No combined-therapy monitoring guidance is included in the provided excerpts (and no text from '7 Drug Interactions' is provided).
Medications that raise potassium levels can increase the risk of hyperkalemia when combined with potassium chloride.
No drug-interaction risk statement is present in the provided excerpts.
The risk of hyperkalemia with potassium chloride is especially relevant with some blood pressure/heart medications.
No specific medication classes are mentioned in the provided excerpts.
The risk of hyperkalemia with potassium chloride is especially relevant with certain kidney-related therapies.
No specific kidney-related therapies are mentioned in the provided excerpts.
Careful medication review and lab monitoring are typically required when potassium chloride is combined with medications that affect potassium levels.
Not present in the provided excerpts.
For potassium chloride, patents and exclusivity typically depend on the specific product formulation, brand, or extended-release version rather than the generic active ingredient itself.
No patent/exclusivity information exists in the provided label excerpts.
Potassium chloride extended-release tablets may require correct administration by patients.
No extended-release administration/counseling text is included in the provided excerpts.
Stomach upset is a side effect to watch for with potassium chloride.
No adverse-reaction content is provided in the excerpts.
High potassium symptoms such as palpitations or unusual weakness may require seeking care.
No patient counseling symptom specifics are present in the provided excerpts.
Contradictions
Low
AI Statement
Too-high potassium levels (hyperkalemia) can cause serious problems.
Label Reference
5.1 Hyperkalemia (ID22)
Important Omissions
FDA-label-supported indication(s) for potassium chloride (e.g., treatment/prevention wording) are not provided in the supplied excerpts, yet the AI claims hypokalemia treatment and prevention as if supported.
Importance:
Moderate
FDA-label-supported route(s) of administration for potassium chloride (oral vs parenteral) are not included in the supplied excerpts, yet the AI asserts both.
Importance:
High
FDA-label-supported contraindications/boxed warning content for potassium chloride is not included in the provided excerpts, limiting safe verification of AI safety statements.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The provided excerpts do not support several key potassium chloride-specific claims (indications, routes, interactions, monitoring specifics, and symptom counseling). While one safety concept (fatal hyperkalemia with potassium administration) is partially reflected, the excerpt is for potassium citrate, not potassium chloride, so incorrect labeling alignment could mislead clinical interpretation.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Many extracted claims are unsupported by the provided FDA label excerpts for potassium chloride; the only hyperkalemia excerpt appears to refer to potassium citrate, not KCl.
Suggested Improvement
Restrict claims strictly to the provided label text (or supply the missing label sections for KCl indications, dosage/administration routes, drug interactions, adverse reactions, and patient counseling), and avoid attributing potassium citrate safety/monitoring language to potassium chloride.